1	Un	Un		C0205447_1	calificador_1	0-2	227_QUEST_clinical_caseMIR	SENT1	-	-
2	paciente	paciente	NCCS000	C0030705	persona	3-11	227_QUEST_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	12-15	227_QUEST_clinical_caseMIR	SENT1	-	-
4	historia	historia	NCFS000	-	-	16-24	227_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0332285	atributo	25-27	227_QUEST_clinical_caseMIR	SENT1	-	-
6	consumo	consumo	NCMS000	C0560219_1	hallazgo_1	28-35	227_QUEST_clinical_caseMIR	SENT1	-	-
7	excesivo	excesivo	NC00SC0	C0560219_2	hallazgo_2	36-44	227_QUEST_clinical_caseMIR	SENT1	-	-
8	de	de	SPS00	C0560219_3	hallazgo_3	45-47	227_QUEST_clinical_caseMIR	SENT1	-	-
9	alcohol	alcohol	NCMS000	C0560219_4	hallazgo_4	48-55	227_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
10	ha	haber	VAIP3S0	-	-	56-58	227_QUEST_clinical_caseMIR	SENT1	-	-
11	sido	ser	VSP00SM	-	-	59-63	227_QUEST_clinical_caseMIR	SENT1	-	-
12	diagnosticado	diagnosticar	VMP00SM	-	-	64-77	227_QUEST_clinical_caseMIR	SENT1	-	-
13	de	de	SPS00	C0332285	atributo	78-80	227_QUEST_clinical_caseMIR	SENT1	-	-
14	tuberculosis	tuberculosis	NCFN000	C0041327_1	trastorno_1	81-93	227_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	pulmonar	pulmonar	NC00SC0	C0041327_2	trastorno_2	94-102	227_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
16	por	por	SPS00	C0678226	atributo	103-106	227_QUEST_clinical_caseMIR	SENT1	-	-
17	un	un		C0205447_1	calificador_1	107-109	227_QUEST_clinical_caseMIR	SENT1	-	-
18	cuadro	cuadro	NCMS000	-	-	110-116	227_QUEST_clinical_caseMIR	SENT1	-	-
19	de	de	SPS00	C0332285	atributo	117-119	227_QUEST_clinical_caseMIR	SENT1	-	-
20	tos	tos	NCFS000	C0010200_1	entidad_observable#hallazgo_1	120-123	227_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
21	,	,	Fc	-	-	123-124	227_QUEST_clinical_caseMIR	SENT1	-	-
22	fiebre	fiebre	NCFS000	C0015967	hallazgo	125-131	227_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
23	,	,	Fc	-	-	131-132	227_QUEST_clinical_caseMIR	SENT1	-	-
24	expectoración	expectoración	NCFS000	C0232515#C0038056	función#sustancia	133-146	227_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
25	,	,	Fc	-	-	146-147	227_QUEST_clinical_caseMIR	SENT1	-	-
26	aislando	aislar	VMG0000	-	-	148-156	227_QUEST_clinical_caseMIR	SENT1	-	-
27	se	se	PP3CN000	-	-	156-158	227_QUEST_clinical_caseMIR	SENT1	-	-
28	en	en	SPS00	C1720294#C0332285	calificador#atributo	159-161	227_QUEST_clinical_caseMIR	SENT1	-	-
29	el	el	DA0MS0	-	-	162-164	227_QUEST_clinical_caseMIR	SENT1	-	-
30	cultivo	cultivo	NCMS000	-	-	165-172	227_QUEST_clinical_caseMIR	SENT1	-	-
31	de	de	SPS00	C0332285	atributo	173-175	227_QUEST_clinical_caseMIR	SENT1	-	-
32	esputo	esputo	NCMS000	C0038056	sustancia	176-182	227_QUEST_clinical_caseMIR	SENT1	-	-
33	Mycobacterium	mycobacterium	NC00SC0	C0026926_1	organismo_1	183-196	227_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
34	tuberculosis	tuberculosis	NCFN000	C0026926_2	organismo_2	197-209	227_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
35	.	.	Fp	-	-	209-210	227_QUEST_clinical_caseMIR	SENT1	-	-

1	El	el	DA0MS0	-	-	211-213	227_QUEST_clinical_caseMIR	SENT2	-	-
2	paciente	paciente	NCCS000	C0030705	persona	214-222	227_QUEST_clinical_caseMIR	SENT2	-	-
3	ha	haber	VAIP3S0	-	-	223-225	227_QUEST_clinical_caseMIR	SENT2	-	-
4	iniciado	iniciar	VMP00SM	-	-	226-234	227_QUEST_clinical_caseMIR	SENT2	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	235-246	227_QUEST_clinical_caseMIR	SENT2	-	-
6	con	con	SPS00	C0332287	atributo	247-250	227_QUEST_clinical_caseMIR	SENT2	-	-
7	isoniacida	isoniacida	NC00SC0	C0022209	producto	251-261	227_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
8	,	,	Fc	-	-	261-262	227_QUEST_clinical_caseMIR	SENT2	-	-
9	rífampicina	rífampicina	NCFS000	-	-	263-274	227_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
10	,	,	Fc	-	-	274-275	227_QUEST_clinical_caseMIR	SENT2	-	-
11	etambutol	etambutol	NC00SC0	C0014964	sustancia	276-285	227_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
12	y	y	CC	C1706368	calificador	286-287	227_QUEST_clinical_caseMIR	SENT2	-	-
13	pirazinamida	pirazinamida	NC00SC0	C0034239	sustancia	288-300	227_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
14	,	,	Fc	-	-	300-301	227_QUEST_clinical_caseMIR	SENT2	-	-
15	con	con	SPS00	C0332287	atributo	302-305	227_QUEST_clinical_caseMIR	SENT2	-	-
16	adecuada	adecuar	VMP00SF	-	-	306-314	227_QUEST_clinical_caseMIR	SENT2	-	-
17	tolerancia	tolerancia	NCFS000	C0231197	entidad_observable	315-325	227_QUEST_clinical_caseMIR	SENT2	-	-
18	.	.	Fp	-	-	325-326	227_QUEST_clinical_caseMIR	SENT2	-	-

1	A	a	SPS00	-	-	327-328	227_QUEST_clinical_caseMIR	SENT3	-	-
2	los	el	DA0MP0	-	-	329-332	227_QUEST_clinical_caseMIR	SENT3	-	-
3	20	20	Z	-	-	333-335	227_QUEST_clinical_caseMIR	SENT3	-	-
4	días	d	NCMP000	-	-	336-340	227_QUEST_clinical_caseMIR	SENT3	-	-
5	del	del	SP+DA	-	-	341-344	227_QUEST_clinical_caseMIR	SENT3	-	-
6	inicio	inicio	NCMS000	C0332162	atributo	345-351	227_QUEST_clinical_caseMIR	SENT3	-	-
7	del	del	SP+DA	-	-	352-355	227_QUEST_clinical_caseMIR	SENT3	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	356-367	227_QUEST_clinical_caseMIR	SENT3	-	-
9	se	se	P00CN000	-	-	368-370	227_QUEST_clinical_caseMIR	SENT3	-	-
10	recibe	recibir	VMIP3S0	-	-	371-377	227_QUEST_clinical_caseMIR	SENT3	-	-
11	un	un		C0205447_1	calificador_1	378-380	227_QUEST_clinical_caseMIR	SENT3	-	-
12	informe	informe	NCMS000	C0684224	elemento_de_registro	381-388	227_QUEST_clinical_caseMIR	SENT3	-	-
13	de	de	SPS00	C0332285	atributo	389-391	227_QUEST_clinical_caseMIR	SENT3	-	-
14	resistencia	resistencia	NCFS000	C0518031	entidad_observable	392-403	227_QUEST_clinical_caseMIR	SENT3	-	-
15	a	a	SPS00	-	-	404-405	227_QUEST_clinical_caseMIR	SENT3	-	-
16	rífampicina	rífampicina	NCFS000	-	-	406-417	227_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
17	del	del	SP+DA	-	-	418-421	227_QUEST_clinical_caseMIR	SENT3	-	-
18	M.	m.	NCFS000	-	-	422-424	227_QUEST_clinical_caseMIR	SENT3	-	-
19	tuberculosis	tuberculosis	NCFN000	C0041296	trastorno	425-437	227_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
20	aislado	aislar	VMP00SM	-	-	438-445	227_QUEST_clinical_caseMIR	SENT3	-	-
21	en	en	SPS00	C1720294#C0332285	calificador#atributo	446-448	227_QUEST_clinical_caseMIR	SENT3	-	-
22	el	el	DA0MS0	-	-	449-451	227_QUEST_clinical_caseMIR	SENT3	-	-
23	esputo	esputo	NCMS000	C0038056	sustancia	452-458	227_QUEST_clinical_caseMIR	SENT3	-	-
24	.	.	Fp	-	-	458-459	227_QUEST_clinical_caseMIR	SENT3	-	-

1	Que	que	CS	-	-	460-463	227_QUEST_clinical_caseMIR	SENT4	-	-
2	régimen	régimen	NCMS000	C0012155	hallazgo	464-471	227_QUEST_clinical_caseMIR	SENT4	-	-
3	seleccionaría	seleccionar	VMIC3S0	-	-	472-485	227_QUEST_clinical_caseMIR	SENT4	-	-
4	en	en	SPS00	C1720294#C0332285	calificador#atributo	486-488	227_QUEST_clinical_caseMIR	SENT4	-	-
5	función	función	NCFS000	C0542341	entidad_observable#atributo	489-496	227_QUEST_clinical_caseMIR	SENT4	-	-
6	de	de	SPS00	C0332285	atributo	497-499	227_QUEST_clinical_caseMIR	SENT4	-	-
7	este	este	DD0MS0	-	-	500-504	227_QUEST_clinical_caseMIR	SENT4	-	-
8	informe	informe	NCMS000	C0684224	elemento_de_registro	505-512	227_QUEST_clinical_caseMIR	SENT4	-	-
9	.	.	Fp	-	-	512-513	227_QUEST_clinical_caseMIR	SENT4	-	-

